These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27526189)

  • 1. Comparative effectiveness of ramosetron for preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis.
    Song HJ; Seo HJ; Son H
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1289-1301. PubMed ID: 27526189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the combination neurokinin-1 receptor antagonist, palonosetron, and dexamethasone compared to others for the prophylaxis of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials.
    Chow R; Tsao M; Chiu L; Popovic M; Milakovic M; Lam H; DeAngelis C
    Ann Palliat Med; 2018 Apr; 7(2):221-233. PubMed ID: 29764184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should palonosetron be a preferred 5-HT
    Chow R; Warr DG; Navari RM; Tsao M; Popovic M; Chiu L; Milakovic M; Lam H; DeAngelis C
    Support Care Cancer; 2018 Aug; 26(8):2519-2549. PubMed ID: 29796708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pinellia ternata-containing traditional Chinese medicine combined with 5-HT3RAs for chemotherapy-induced nausea and vomiting: A PRISMA-compliant systematic review and meta-analysis of 22 RCTs.
    Zhai X; He Q; Chen M; Yu L; Tong C; Chen Y; Wang J; Fan X; Xie H; Liang Z; Sui X; Zeng L; Wu Q
    Phytomedicine; 2023 Jul; 115():154823. PubMed ID: 37099981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.
    Kim HJ; Shin SW; Song EK; Lee NR; Kim JS; Ahn JS; Yun HJ; Cho YH; Park KU; Kim SY; Jang JS; Kim SW; Lee HW; Lee SR; Kim YS; Lee SN; Ko YH; Kim HJ; Kang JH
    Oncologist; 2015 Dec; 20(12):1440-7. PubMed ID: 26512046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting.
    Rabasseda X
    Drugs Today (Barc); 2002 Feb; 38(2):75-89. PubMed ID: 12532186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety and effectiveness of ondansetron compared to other serotonin-3 receptor antagonists (5-HT3RAs) used to control chemotherapy-induced nausea and vomiting: systematic review and meta-analysis.
    Simino GP; Marra LP; Andrade EI; Acúrcio Fde A; Reis IA; De Araújo VE; Cherchiglia ML
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1183-94. PubMed ID: 27180992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting.
    Kim KR; Kang G; Ki MS; Shim HJ; Hwang JE; Bae WK; Chung IJ; Kim JK; Jeong S; Cho SH
    Biomed Res Int; 2015; 2015():523601. PubMed ID: 26421292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of Ramosetron injections in the treatment of cisplatin-induced nausea and vomiting.
    Noda K; Ikeda M; Yoshida O; Yano S; Taguchi T; Shimoyama T; Nakashima M
    J Int Med Res; 2002; 30(3):211-9. PubMed ID: 12166337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.
    Chow R; Valdez C; Chow N; Zhang D; Im J; Sodhi E; Lock M
    Support Care Cancer; 2020 May; 28(5):2095-2103. PubMed ID: 31916006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of ramosetron versus ondansetron for postoperative nausea and vomiting after general anesthesia: a meta-analysis of randomized clinical trials.
    Gao C; Li B; Xu L; Lv F; Cao G; Wang H; Wang F; Wu G
    Drug Des Devel Ther; 2015; 9():2343-50. PubMed ID: 25960637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative safety and effectiveness of serotonin receptor antagonists in patients undergoing chemotherapy: a systematic review and network meta-analysis.
    Tricco AC; Blondal E; Veroniki AA; Soobiah C; Vafaei A; Ivory J; Strifler L; Cardoso R; Reynen E; Nincic V; Ashoor H; Ho J; Ng C; Johnson C; Lillie E; Antony J; Roberts DJ; Hemmelgarn BR; Straus SE
    BMC Med; 2016 Dec; 14(1):216. PubMed ID: 28007031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review.
    Chow R; Chiu L; Navari R; Passik S; Chiu N; Popovic M; Lam H; Pasetka M; Chow E; DeAngelis C
    Support Care Cancer; 2016 Feb; 24(2):1001-1008. PubMed ID: 26530228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis.
    Yoodee J; Permsuwan U; Nimworapan M
    Crit Rev Oncol Hematol; 2017 Apr; 112():113-125. PubMed ID: 28325253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting.
    Ho CL; Su WC; Hsieh RK; Lin ZZ; Chao TY
    Jpn J Clin Oncol; 2010 Apr; 40(4):294-301. PubMed ID: 20026457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.
    Jin Y; Sun W; Gu D; Yang J; Xu Z; Chen J
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):41-50. PubMed ID: 22519361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
    Natale JJ
    Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.
    Tafelski S; Häuser W; Schäfer M
    Schmerz; 2016 Feb; 30(1):14-24. PubMed ID: 26787227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Palonosetron vs. Ramosetron for the Prevention of Postoperative Nausea and Vomiting: A Meta-Analysis of Randomized Controlled Trials.
    Kim MS; Park JH; Choi YS; Park SH; Shin S
    Yonsei Med J; 2017 Jul; 58(4):848-858. PubMed ID: 28541001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.